 | • レポートコード：MRC2-11QY11625 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器・消耗品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は糖尿病治療装置・薬剤のグローバル市場について調査・分析したレポートです。種類別（インスリン、速効型インスリン、短時間作用型インスリン、糖尿病治療装置、糖尿病モニタリング装置、その他）市場規模、用途別（病院、家庭）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別糖尿病治療装置・薬剤の競争状況、市場シェア ・世界の糖尿病治療装置・薬剤市場：種類別市場規模 2015年-2020年（インスリン、速効型インスリン、短時間作用型インスリン、糖尿病治療装置、糖尿病モニタリング装置、その他） ・世界の糖尿病治療装置・薬剤市場：種類別市場規模予測 2021年-2026年（インスリン、速効型インスリン、短時間作用型インスリン、糖尿病治療装置、糖尿病モニタリング装置、その他） ・世界の糖尿病治療装置・薬剤市場：用途別市場規模 2015年-2020年（病院、家庭） ・世界の糖尿病治療装置・薬剤市場：用途別市場規模予測 2021年-2026年（病院、家庭） ・北米の糖尿病治療装置・薬剤市場分析：米国、カナダ ・ヨーロッパの糖尿病治療装置・薬剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの糖尿病治療装置・薬剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の糖尿病治療装置・薬剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの糖尿病治療装置・薬剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Ascensia Diabetes Care Holdings、AstraZeneca、Boehringer Ingelheim GmbH、Eli Lilly And、Hoffmann-La Roche、Johnson & Johnson、Medtronic PLC、Novartis、Novo Nordisk A/S、Ypsomed、Terumo ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Diabetes Care Devices & Drugs is used to treat diabetes equipment and drugs.
The global diabetes care devices & drugs market is mainly driven by thereasingidence & prevalence of diabetes, technological advancements, rising obesity rate, andreasingdentary lifestyle & improper diet.
Market Analysis and Insights: Global Diabetes Care Devices & Drugs Market
The global Diabetes Care Devices & Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Diabetes Care Devices & Drugs Scope and Market Size
Diabetes Care Devices & Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diabetes Care Devices & Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboratories
Ascensia Diabetes Care Holdings
AstraZeneca
Boehringer Ingelheim GmbH
Eli Lilly And
Hoffmann-La Roche
Johnson & Johnson
Medtronic PLC
Novartis
Novo Nordisk A/S
Ypsomed
Terumo
Market segment by Type, the product can be split into
Insulin
Rapid Acting Insulin
Short Acting Insulin
Diabetes Care Devices
Diabetes Monitoring Devices
Other
Market segment by Application, split into
Hospital
Household
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Diabetes Care Devices & Drugs Revenue
1.4 Market by Type
1.4.1 Global Diabetes Care Devices & Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Insulin
1.4.3 Rapid Acting Insulin
1.4.4 Short Acting Insulin
1.4.5 Diabetes Care Devices
1.4.6 Diabetes Monitoring Devices
1.4.7 Other
1.5 Market by Application
1.5.1 Global Diabetes Care Devices & Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Household
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Care Devices & Drugs Market Perspective (2015-2026)
2.2 Global Diabetes Care Devices & Drugs Growth Trends by Regions
2.2.1 Diabetes Care Devices & Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Diabetes Care Devices & Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Diabetes Care Devices & Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Diabetes Care Devices & Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Diabetes Care Devices & Drugs Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Diabetes Care Devices & Drugs Players by Market Size
3.1.1 Global Top Diabetes Care Devices & Drugs Players by Revenue (2015-2020)
3.1.2 Global Diabetes Care Devices & Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Diabetes Care Devices & Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Diabetes Care Devices & Drugs Market Concentration Ratio
3.2.1 Global Diabetes Care Devices & Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Diabetes Care Devices & Drugs Revenue in 2019
3.3 Diabetes Care Devices & Drugs Key Players Head office and Area Served
3.4 Key Players Diabetes Care Devices & Drugs Product Solution and Service
3.5 Date of Enter into Diabetes Care Devices & Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Diabetes Care Devices & Drugs Historic Market Size by Type (2015-2020)
4.2 Global Diabetes Care Devices & Drugs Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Diabetes Care Devices & Drugs Market Size by Application (2015-2020)
5.2 Global Diabetes Care Devices & Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Diabetes Care Devices & Drugs Market Size (2015-2020)
6.2 Diabetes Care Devices & Drugs Key Players in North America (2019-2020)
6.3 North America Diabetes Care Devices & Drugs Market Size by Type (2015-2020)
6.4 North America Diabetes Care Devices & Drugs Market Size by Application (2015-2020)
7 Europe
7.1 Europe Diabetes Care Devices & Drugs Market Size (2015-2020)
7.2 Diabetes Care Devices & Drugs Key Players in Europe (2019-2020)
7.3 Europe Diabetes Care Devices & Drugs Market Size by Type (2015-2020)
7.4 Europe Diabetes Care Devices & Drugs Market Size by Application (2015-2020)
8 China
8.1 China Diabetes Care Devices & Drugs Market Size (2015-2020)
8.2 Diabetes Care Devices & Drugs Key Players in China (2019-2020)
8.3 China Diabetes Care Devices & Drugs Market Size by Type (2015-2020)
8.4 China Diabetes Care Devices & Drugs Market Size by Application (2015-2020)
9 Japan
9.1 Japan Diabetes Care Devices & Drugs Market Size (2015-2020)
9.2 Diabetes Care Devices & Drugs Key Players in Japan (2019-2020)
9.3 Japan Diabetes Care Devices & Drugs Market Size by Type (2015-2020)
9.4 Japan Diabetes Care Devices & Drugs Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Diabetes Care Devices & Drugs Market Size (2015-2020)
10.2 Diabetes Care Devices & Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Diabetes Care Devices & Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Diabetes Care Devices & Drugs Market Size by Application (2015-2020)
11 India
11.1 India Diabetes Care Devices & Drugs Market Size (2015-2020)
11.2 Diabetes Care Devices & Drugs Key Players in India (2019-2020)
11.3 India Diabetes Care Devices & Drugs Market Size by Type (2015-2020)
11.4 India Diabetes Care Devices & Drugs Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Diabetes Care Devices & Drugs Market Size (2015-2020)
12.2 Diabetes Care Devices & Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Diabetes Care Devices & Drugs Market Size by Type (2015-2020)
12.4 Central & South America Diabetes Care Devices & Drugs Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories Diabetes Care Devices & Drugs Introduction
13.1.4 Abbott Laboratories Revenue in Diabetes Care Devices & Drugs Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Ascensia Diabetes Care Holdings
13.2.1 Ascensia Diabetes Care Holdings Company Details
13.2.2 Ascensia Diabetes Care Holdings Business Overview
13.2.3 Ascensia Diabetes Care Holdings Diabetes Care Devices & Drugs Introduction
13.2.4 Ascensia Diabetes Care Holdings Revenue in Diabetes Care Devices & Drugs Business (2015-2020)
13.2.5 Ascensia Diabetes Care Holdings Recent Development
13.3 AstraZeneca
13.3.1 AstraZeneca Company Details
13.3.2 AstraZeneca Business Overview
13.3.3 AstraZeneca Diabetes Care Devices & Drugs Introduction
13.3.4 AstraZeneca Revenue in Diabetes Care Devices & Drugs Business (2015-2020)
13.3.5 AstraZeneca Recent Development
13.4 Boehringer Ingelheim GmbH
13.4.1 Boehringer Ingelheim GmbH Company Details
13.4.2 Boehringer Ingelheim GmbH Business Overview
13.4.3 Boehringer Ingelheim GmbH Diabetes Care Devices & Drugs Introduction
13.4.4 Boehringer Ingelheim GmbH Revenue in Diabetes Care Devices & Drugs Business (2015-2020)
13.4.5 Boehringer Ingelheim GmbH Recent Development
13.5 Eli Lilly And
13.5.1 Eli Lilly And Company Details
13.5.2 Eli Lilly And Business Overview
13.5.3 Eli Lilly And Diabetes Care Devices & Drugs Introduction
13.5.4 Eli Lilly And Revenue in Diabetes Care Devices & Drugs Business (2015-2020)
13.5.5 Eli Lilly And Recent Development
13.6 Hoffmann-La Roche
13.6.1 Hoffmann-La Roche Company Details
13.6.2 Hoffmann-La Roche Business Overview
13.6.3 Hoffmann-La Roche Diabetes Care Devices & Drugs Introduction
13.6.4 Hoffmann-La Roche Revenue in Diabetes Care Devices & Drugs Business (2015-2020)
13.6.5 Hoffmann-La Roche Recent Development
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Details
13.7.2 Johnson & Johnson Business Overview
13.7.3 Johnson & Johnson Diabetes Care Devices & Drugs Introduction
13.7.4 Johnson & Johnson Revenue in Diabetes Care Devices & Drugs Business (2015-2020)
13.7.5 Johnson & Johnson Recent Development
13.8 Medtronic PLC
13.8.1 Medtronic PLC Company Details
13.8.2 Medtronic PLC Business Overview
13.8.3 Medtronic PLC Diabetes Care Devices & Drugs Introduction
13.8.4 Medtronic PLC Revenue in Diabetes Care Devices & Drugs Business (2015-2020)
13.8.5 Medtronic PLC Recent Development
13.9 Novartis
13.9.1 Novartis Company Details
13.9.2 Novartis Business Overview
13.9.3 Novartis Diabetes Care Devices & Drugs Introduction
13.9.4 Novartis Revenue in Diabetes Care Devices & Drugs Business (2015-2020)
13.9.5 Novartis Recent Development
13.10 Novo Nordisk A/S
13.10.1 Novo Nordisk A/S Company Details
13.10.2 Novo Nordisk A/S Business Overview
13.10.3 Novo Nordisk A/S Diabetes Care Devices & Drugs Introduction
13.10.4 Novo Nordisk A/S Revenue in Diabetes Care Devices & Drugs Business (2015-2020)
13.10.5 Novo Nordisk A/S Recent Development
13.11 Ypsomed
10.11.1 Ypsomed Company Details
10.11.2 Ypsomed Business Overview
10.11.3 Ypsomed Diabetes Care Devices & Drugs Introduction
10.11.4 Ypsomed Revenue in Diabetes Care Devices & Drugs Business (2015-2020)
10.11.5 Ypsomed Recent Development
13.12 Terumo
10.12.1 Terumo Company Details
10.12.2 Terumo Business Overview
10.12.3 Terumo Diabetes Care Devices & Drugs Introduction
10.12.4 Terumo Revenue in Diabetes Care Devices & Drugs Business (2015-2020)
10.12.5 Terumo Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Diabetes Care Devices & Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Diabetes Care Devices & Drugs Revenue
Table 3. Ranking of Global Top Diabetes Care Devices & Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Diabetes Care Devices & Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Insulin
Table 6. Key Players of Rapid Acting Insulin
Table 7. Key Players of Short Acting Insulin
Table 8. Key Players of Diabetes Care Devices
Table 9. Key Players of Diabetes Monitoring Devices
Table 10. Key Players of Other
Table 11. Global Diabetes Care Devices & Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Diabetes Care Devices & Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Diabetes Care Devices & Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Diabetes Care Devices & Drugs Market Share by Regions (2015-2020)
Table 15. Global Diabetes Care Devices & Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Diabetes Care Devices & Drugs Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Diabetes Care Devices & Drugs Market Growth Strategy
Table 21. Main Points Interviewed from Key Diabetes Care Devices & Drugs Players
Table 22. Global Diabetes Care Devices & Drugs Revenue by Players (2015-2020) (Million US$)
Table 23. Global Diabetes Care Devices & Drugs Market Share by Players (2015-2020)
Table 24. Global Top Diabetes Care Devices & Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Care Devices & Drugs as of 2019)
Table 25. Global Diabetes Care Devices & Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Diabetes Care Devices & Drugs Product Solution and Service
Table 28. Date of Enter into Diabetes Care Devices & Drugs Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Diabetes Care Devices & Drugs Market Size by Type (2015-2020) (Million US$)
Table 31. Global Diabetes Care Devices & Drugs Market Size Share by Type (2015-2020)
Table 32. Global Diabetes Care Devices & Drugs Revenue Market Share by Type (2021-2026)
Table 33. Global Diabetes Care Devices & Drugs Market Size Share by Application (2015-2020)
Table 34. Global Diabetes Care Devices & Drugs Market Size by Application (2015-2020) (Million US$)
Table 35. Global Diabetes Care Devices & Drugs Market Size Share by Application (2021-2026)
Table 36. North America Key Players Diabetes Care Devices & Drugs Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Diabetes Care Devices & Drugs Market Share (2019-2020)
Table 38. North America Diabetes Care Devices & Drugs Market Size by Type (2015-2020) (Million US$)
Table 39. North America Diabetes Care Devices & Drugs Market Share by Type (2015-2020)
Table 40. North America Diabetes Care Devices & Drugs Market Size by Application (2015-2020) (Million US$)
Table 41. North America Diabetes Care Devices & Drugs Market Share by Application (2015-2020)
Table 42. Europe Key Players Diabetes Care Devices & Drugs Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Diabetes Care Devices & Drugs Market Share (2019-2020)
Table 44. Europe Diabetes Care Devices & Drugs Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Diabetes Care Devices & Drugs Market Share by Type (2015-2020)
Table 46. Europe Diabetes Care Devices & Drugs Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Diabetes Care Devices & Drugs Market Share by Application (2015-2020)
Table 48. China Key Players Diabetes Care Devices & Drugs Revenue (2019-2020) (Million US$)
Table 49. China Key Players Diabetes Care Devices & Drugs Market Share (2019-2020)
Table 50. China Diabetes Care Devices & Drugs Market Size by Type (2015-2020) (Million US$)
Table 51. China Diabetes Care Devices & Drugs Market Share by Type (2015-2020)
Table 52. China Diabetes Care Devices & Drugs Market Size by Application (2015-2020) (Million US$)
Table 53. China Diabetes Care Devices & Drugs Market Share by Application (2015-2020)
Table 54. Japan Key Players Diabetes Care Devices & Drugs Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Diabetes Care Devices & Drugs Market Share (2019-2020)
Table 56. Japan Diabetes Care Devices & Drugs Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Diabetes Care Devices & Drugs Market Share by Type (2015-2020)
Table 58. Japan Diabetes Care Devices & Drugs Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Diabetes Care Devices & Drugs Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Diabetes Care Devices & Drugs Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Diabetes Care Devices & Drugs Market Share (2019-2020)
Table 62. Southeast Asia Diabetes Care Devices & Drugs Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Diabetes Care Devices & Drugs Market Share by Type (2015-2020)
Table 64. Southeast Asia Diabetes Care Devices & Drugs Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Diabetes Care Devices & Drugs Market Share by Application (2015-2020)
Table 66. India Key Players Diabetes Care Devices & Drugs Revenue (2019-2020) (Million US$)
Table 67. India Key Players Diabetes Care Devices & Drugs Market Share (2019-2020)
Table 68. India Diabetes Care Devices & Drugs Market Size by Type (2015-2020) (Million US$)
Table 69. India Diabetes Care Devices & Drugs Market Share by Type (2015-2020)
Table 70. India Diabetes Care Devices & Drugs Market Size by Application (2015-2020) (Million US$)
Table 71. India Diabetes Care Devices & Drugs Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Diabetes Care Devices & Drugs Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Diabetes Care Devices & Drugs Market Share (2019-2020)
Table 74. Central & South America Diabetes Care Devices & Drugs Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Diabetes Care Devices & Drugs Market Share by Type (2015-2020)
Table 76. Central & South America Diabetes Care Devices & Drugs Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Diabetes Care Devices & Drugs Market Share by Application (2015-2020)
Table 78. Abbott Laboratories Company Details
Table 79. Abbott Laboratories Business Overview
Table 80. Abbott Laboratories Product
Table 81. Abbott Laboratories Revenue in Diabetes Care Devices & Drugs Business (2015-2020) (Million US$)
Table 82. Abbott Laboratories Recent Development
Table 83. Ascensia Diabetes Care Holdings Company Details
Table 84. Ascensia Diabetes Care Holdings Business Overview
Table 85. Ascensia Diabetes Care Holdings Product
Table 86. Ascensia Diabetes Care Holdings Revenue in Diabetes Care Devices & Drugs Business (2015-2020) (Million US$)
Table 87. Ascensia Diabetes Care Holdings Recent Development
Table 88. AstraZeneca Company Details
Table 89. AstraZeneca Business Overview
Table 90. AstraZeneca Product
Table 91. AstraZeneca Revenue in Diabetes Care Devices & Drugs Business (2015-2020) (Million US$)
Table 92. AstraZeneca Recent Development
Table 93. Boehringer Ingelheim GmbH Company Details
Table 94. Boehringer Ingelheim GmbH Business Overview
Table 95. Boehringer Ingelheim GmbH Product
Table 96. Boehringer Ingelheim GmbH Revenue in Diabetes Care Devices & Drugs Business (2015-2020) (Million US$)
Table 97. Boehringer Ingelheim GmbH Recent Development
Table 98. Eli Lilly And Company Details
Table 99. Eli Lilly And Business Overview
Table 100. Eli Lilly And Product
Table 101. Eli Lilly And Revenue in Diabetes Care Devices & Drugs Business (2015-2020) (Million US$)
Table 102. Eli Lilly And Recent Development
Table 103. Hoffmann-La Roche Company Details
Table 104. Hoffmann-La Roche Business Overview
Table 105. Hoffmann-La Roche Product
Table 106. Hoffmann-La Roche Revenue in Diabetes Care Devices & Drugs Business (2015-2020) (Million US$)
Table 107. Hoffmann-La Roche Recent Development
Table 108. Johnson & Johnson Company Details
Table 109. Johnson & Johnson Business Overview
Table 110. Johnson & Johnson Product
Table 111. Johnson & Johnson Revenue in Diabetes Care Devices & Drugs Business (2015-2020) (Million US$)
Table 112. Johnson & Johnson Recent Development
Table 113. Medtronic PLC Business Overview
Table 114. Medtronic PLC Product
Table 115. Medtronic PLC Company Details
Table 116. Medtronic PLC Revenue in Diabetes Care Devices & Drugs Business (2015-2020) (Million US$)
Table 117. Medtronic PLC Recent Development
Table 118. Novartis Company Details
Table 119. Novartis Business Overview
Table 120. Novartis Product
Table 121. Novartis Revenue in Diabetes Care Devices & Drugs Business (2015-2020) (Million US$)
Table 122. Novartis Recent Development
Table 123. Novo Nordisk A/S Company Details
Table 124. Novo Nordisk A/S Business Overview
Table 125. Novo Nordisk A/S Product
Table 126. Novo Nordisk A/S Revenue in Diabetes Care Devices & Drugs Business (2015-2020) (Million US$)
Table 127. Novo Nordisk A/S Recent Development
Table 128. Ypsomed Company Details
Table 129. Ypsomed Business Overview
Table 130. Ypsomed Product
Table 131. Ypsomed Revenue in Diabetes Care Devices & Drugs Business (2015-2020) (Million US$)
Table 132. Ypsomed Recent Development
Table 133. Terumo Company Details
Table 134. Terumo Business Overview
Table 135. Terumo Product
Table 136. Terumo Revenue in Diabetes Care Devices & Drugs Business (2015-2020) (Million US$)
Table 137. Terumo Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetes Care Devices & Drugs Market Share by Type: 2020 VS 2026
Figure 2. Insulin Features
Figure 3. Rapid Acting Insulin Features
Figure 4. Short Acting Insulin Features
Figure 5. Diabetes Care Devices Features
Figure 6. Diabetes Monitoring Devices Features
Figure 7. Other Features
Figure 8. Global Diabetes Care Devices & Drugs Market Share by Application: 2020 VS 2026
Figure 9. Hospital Case Studies
Figure 10. Household Case Studies
Figure 11. Diabetes Care Devices & Drugs Report Years Considered
Figure 12. Global Diabetes Care Devices & Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Diabetes Care Devices & Drugs Market Share by Regions: 2020 VS 2026
Figure 14. Global Diabetes Care Devices & Drugs Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Diabetes Care Devices & Drugs Market Share by Players in 2019
Figure 17. Global Top Diabetes Care Devices & Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Care Devices & Drugs as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Diabetes Care Devices & Drugs Revenue in 2019
Figure 19. North America Diabetes Care Devices & Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Diabetes Care Devices & Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Diabetes Care Devices & Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Diabetes Care Devices & Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Diabetes Care Devices & Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Diabetes Care Devices & Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Diabetes Care Devices & Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
無針糖尿病治療の世界市場（～2026年） Diabetes is a metabolic disorder in this condition person will have high blood glucose levels than the normal blood glucose. This is mainly due to inadequate insulin production or body cells are unable to respond to the produced insulin in the body or both. Symptoms of Diabetes are hyperglycemic con…- 糖尿病用非インスリン療法の世界市場（～2026年） Market Analysis and Insights: Global Non-Insulin Therapies for Diabetes Market The global Non-Insulin Therapies for Diabetes market size is projected to reach US$ 32930 million by 2026, from US$ 30040 million in 2020, at a CAGR of 8.9%% during 2021-2026. Global Non-Insulin Therapies for Diabetes Sco…
- 糖尿病治療の世界市場（～2026年） Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system. As living standards improve, an increasing obesity, the Diabetes Treatment has improved people's living habits, disease control effect, is becoming m…
- CISインスリンの世界市場（～2026年） Insulin is a peptide hormone produced by beta cells of the pancreatic islets, which is considered to be the main anabolic hormone of the body. Russia is estimated to witness a significant growth over the next decade owing to the various subsidies provided by the local government. Market Analysis and…
- 1型糖尿病の世界市場（～2026年） Type 1 diabetes is a form of diabetes mellitus in which very little or no insulin is produced by the pancreas. The global type 1 diabetes market is expected to grow modestly during the forecast period owing to growing incidence and prevalence of diabetes and cohesive government policies. Market Anal…